Benzinga | May 6, 2021 04:51PM EDT

Amphastar Pharmaceuticals Q1 EPS $0.27 Beats $0.18 Estimate, Sales $103.02M Beat $97.26M Estimate

Amphastar Pharmaceuticals (NASDAQ:AMPH) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.18 by 50 percent. This is a 58.82 percent increase over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $103.02 million which beat the analyst consensus estimate of $97.26 million by 5.92 percent. This is a 21.65 percent increase over sales of $84.69 million the same period last year.